CHAPTER 1. Industry Overview of Artificial Intelligence in Genomics Market
1.1. Definition and Scope
1.1.1. Definition of Artificial Intelligence in Genomics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Artificial Intelligence in Genomics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Artificial Intelligence in Genomics Market By Offering
1.2.3. Artificial Intelligence in Genomics Market By Technology
1.2.4. Artificial Intelligence in Genomics Market By Application
1.2.5. Artificial Intelligence in Genomics Market By Functionality
1.2.6. Artificial Intelligence in Genomics Market By End-User
1.2.7. Artificial Intelligence in Genomics Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Artificial Intelligence in Genomics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Artificial Intelligence in Genomics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Artificial Intelligence in Genomics Market By Offering
4.1. Introduction
4.2. Artificial Intelligence in GenomicsRevenueBy Offering
4.2.1. Artificial Intelligence in Genomics Revenue (USD Million) and Forecast, By Offering, 2018-2030
4.2.2. Software
4.2.2.1. Software Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3. Services
4.2.3.1. Services Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 5. Artificial Intelligence in Genomics Market By Technology
5.1. Introduction
5.2. Artificial Intelligence in Genomics Revenue (USD Million) By Technology
5.2.1. Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
5.2.2. Machine Learning
5.2.2.1. Machine Learning Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.2.2. Deep Learning
5.2.2.2.1. Deep LearningMarket Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.2.3. Supervised Learning
5.2.2.3.1. Supervised Learning Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.2.4. Reinforcement Learning
5.2.2.4.1. Reinforcement Learning Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.2.5. Unsupervised Learning
5.2.2.5.1. Unsupervised Learning Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.2.6. Other Machine Learning Technologies
5.2.2.6.1. Other Machine Learning Technologies Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3. Other Technologies
5.2.3.1. Other Technologies Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 6. Artificial Intelligence in Genomics Market By Application
6.1. Introduction
6.2. Artificial Intelligence in Genomics Revenue (USD Million) By Application
6.2.1. Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
6.2.2. Diagnostics
6.2.2.1. Diagnostics Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.3. Drug Discovery & Development
6.2.3.1. Drug Discovery & Development Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.4. Precision Medicine
6.2.4.1. Precision Medicine Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.5. Agriculture & Animal Research
6.2.5.1. Agriculture & Animal Research Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.6. Other Applications
6.2.6.1. Other Applications Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 7. Artificial Intelligence in Genomics Market By Functionality
7.1. Introduction
7.2. Artificial Intelligence in Genomics Revenue (USD Million) By Functionality
7.2.1. Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
7.2.2. Genome Sequencing
7.2.2.1. Genome Sequencing Market Revenue (USD Million) and Growth Rate (%), 2018-2030
7.2.3. Gene Editing
7.2.3.1. Gene Editing Market Revenue (USD Million) and Growth Rate (%), 2018-2030
7.2.4. Clinical Workflows
7.2.4.1. Clinical Workflows Market Revenue (USD Million) and Growth Rate (%), 2018-2030
7.2.5. Predictive Genetic Testing & Preventive Medicine
7.2.5.1. Predictive Genetic Testing & Preventive Medicine Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 8. Artificial Intelligence in Genomics Market By End-User
8.1. Introduction
8.2. Artificial Intelligence in Genomics Revenue By End-User
8.2.1. Artificial Intelligence in Genomics Revenue (USD Million) and Forecast,By End-User, 2018-2030
8.2.2. Pharmaceutical & Biotech Companies
8.2.2.1. Pharmaceutical & Biotech CompaniesMarket Revenue (USD Million) and Growth Rate (%), 2018-2030
8.2.3. Healthcare Providers
8.2.3.1. Healthcare Providers Market Revenue (USD Million) and Growth Rate (%), 2018-2030
8.2.4. Academic Institutes, Research Centers, & Government Organizations
8.2.4.1. Academic Institutes, Research Centers, & Government Organizations Market Revenue (USD Million) and Growth Rate (%), 2018-2030
8.2.5. Other End-Users
8.2.5.1. Other End-Users Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 9. North America Artificial Intelligence in Genomics Market By Country
9.1. North America Artificial Intelligence in GenomicsMarket Overview
9.2. U.S.
9.2.1. U.S. Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
9.2.2. U.S. Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
9.2.3. U.S. Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
9.2.4. U.S. Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Functionality, 2018-2030
9.2.5. U.S. Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
9.3. Canada
9.3.1. Canada Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
9.3.2. Canada Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
9.3.3. Canada Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
9.3.4. Canada Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
9.3.5. Canada Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
9.4. North America PEST Analysis
CHAPTER 10. Europe Artificial Intelligence in Genomics Market By Country
10.1. Europe Artificial Intelligence in GenomicsMarket Overview
10.2. U.K.
10.2.1. U.K. Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
10.2.2. U.K. Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
10.2.3. U.K. Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
10.2.4. U.K. Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
10.2.5. U.K. Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
10.3. Germany
10.3.1. Germany Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
10.3.2. Germany Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
10.3.3. Germany Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
10.3.4. Germany Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
10.3.5. Germany Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
10.4. France
10.4.1. France Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
10.4.2. France Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
10.4.3. France Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
10.4.4. France Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
10.4.5. France Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
10.5. Spain
10.5.1. Spain Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
10.5.2. Spain Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
10.5.3. Spain Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
10.5.4. Spain Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
10.5.5. Spain Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
10.6. Rest of Europe
10.6.1. Rest of Europe Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
10.6.2. Rest of Europe Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
10.6.3. Rest of Europe Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
10.6.4. Rest of Europe Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
10.6.5. Rest of Europe Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Artificial Intelligence in Genomics Market By Country
11.1. Asia Pacific Artificial Intelligence in GenomicsMarket Overview
11.2. China
11.2.1. China Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
11.2.2. China Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
11.2.3. China Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
11.2.4. China Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
11.2.5. China Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
11.3. Japan
11.3.1. Japan Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
11.3.2. Japan Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
11.3.3. Japan Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
11.3.4. Japan Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
11.3.5. Japan Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
11.4. India
11.4.1. India Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
11.4.2. India Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
11.4.3. India Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
11.4.4. India Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
11.4.5. India Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
11.5. Australia
11.5.1. Australia Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
11.5.2. Australia Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
11.5.3. Australia Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
11.5.4. Australia Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
11.5.5. Australia Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
11.6. South Korea
11.6.1. South Korea Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
11.6.2. South Korea Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
11.6.3. South Korea Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
11.6.4. South Korea Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
11.6.5. South Korea Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
11.7.2. Rest of Asia-Pacific Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
11.7.3. Rest of Asia-Pacific Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
11.7.4. Rest of Asia-Pacific Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
11.7.5. Rest of Asia-Pacific Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Artificial Intelligence in Genomics Market By Country
12.1. Latin America Artificial Intelligence in GenomicsMarket Overview
12.2. Brazil
12.2.1. Brazil Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
12.2.2. Brazil Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
12.2.3. Brazil Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
12.2.4. Brazil Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
12.2.5. Brazil Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
12.3. Mexico
12.3.1. MexicoArtificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
12.3.2. Mexico Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
12.3.3. Mexico Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
12.3.4. Mexico Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
12.3.5. Mexico Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
12.4. Rest of Latin America
12.4.1. Rest of Latin America Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
12.4.2. Rest of Latin America Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
12.4.3. Rest of Latin America Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
12.4.4. Rest of Latin America Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
12.4.5. Rest of Latin America Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Artificial Intelligence in Genomics Market By Country
13.1. Middle East & Africa Artificial Intelligence in GenomicsMarket Overview
13.2. GCC
13.2.1. GCCArtificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
13.2.2. GCC Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
13.2.3. GCC Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
13.2.4. GCC Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
13.2.5. GCC Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
13.3. South Africa
13.3.1. South AfricaArtificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
13.3.2. South Africa Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
13.3.3. South Africa Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
13.3.4. South Africa Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
13.3.5. South Africa Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & AfricaArtificial Intelligence in Genomics Revenue (USD Million) and Forecast By Offering, 2018-2030
13.4.2. Rest of Middle East & Africa Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Technology, 2018-2030
13.4.3. Rest of Middle East & Africa Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By Application, 2018-2030
13.4.4. Rest of Middle East & Africa Artificial Intelligence in Genomics Revenue (USD Million) and Forecast ByFunctionality, 2018-2030
13.4.5. Rest of Middle East & Africa Artificial Intelligence in Genomics Revenue (USD Million) and Forecast By End-User, 2018-2030
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Artificial Intelligence in Genomics Market
14.1. Artificial Intelligence in Genomics MarketCompany Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investments
14.2.2. New Product Launches and ProductEnhancement
14.2.3. Mergers And Acquisition InGlobal Artificial Intelligence in Genomics Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. BenevolentAI
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Million), 2021
15.1.3.2. BenevolentAI2021 Artificial Intelligence in GenomicsBusiness Regional Distribution
15.1.4. Product/Service and Specification
15.1.5. Recent Developments& Business Strategy
15.1.6. Manufacturing Plant Footprint Analysis
15.2. Cambridge Cancer Genomics
15.3. Data4Cure Inc.
15.4. Deep Genomics
15.5. Fabric Genomics Inc.
15.6. Freenome Holdings, Inc.
15.7. Genoox Ltd.
15.8. IBM
15.9. Lifebit
15.10. Microsoft
15.11. MolecularMatch Inc.
15.12. NVIDIA Corporation
15.13. PrecisionLife Ltd.
15.14. SOPHiA GENETICS
15.15. Verge Genomics
The global artificial intelligence in genomics market size in 2021 was accounted to be USD 471 Million.
The projected CAGR of artificial intelligence in genomics market during the analysis period of 2022 to 2030 is 50.2%.
The prominent players of the global artificial intelligence in genomics market involve BenevolentAI, Cambridge Cancer Genomics, Data4Cure Inc., Deep Genomics, Fabric Genomics Inc., Freenome Holdings, Inc., Genoox Ltd., IBM, Lifebit Microsoft, Molecular Match Inc., NVIDIA Corporation, Precision Life Ltd., SOPHiA GENETICS, and Verge Genomics.
North America held the dominating share for artificial intelligence in genomics during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for artificial intelligence in genomics during the analysis period of 2022 to 2030.
Rising adoption of AI in precision medicine, need to control the time and costs of drug development and discovery, and growing genomic datasets drives the growth of global artificial intelligence in genomics market.
Based on offering, software sub-segment held the maximum share for artificial intelligence in genomics market in 2021.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date